Monopar Therapeutics Inc (MNPR) support and resistance · $431.4M cap
Monopar Therapeutics Inc (MNPR) is a biotechnology company listed on US.
This page maps Monopar Therapeutics Inc (MNPR) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported MNPR revenue for 2026-06-30 was $0. Net income was -$9.2M. MNPR currently screens at market cap $431.4M.
MNPR currently screens at market cap $431.4M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new MNPR 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the MNPR quote page for the session range and the stock page for the full model.
Not investment advice.